倍他乐克联合卡托普利治疗舒张性心力衰竭的疗效分析

Efficacy of Betaloc Combined with Captopril in the Treatment of Diastolic Heart Failure

目的探讨倍他乐克联合卡托普利治疗舒张性心力衰竭的临床效果。方法选择我院收治的150例舒张性心力衰竭患者,随机分为观察组和对照组,对照组采用心力衰竭常规治疗,观察组在常规治疗基础上给予倍他乐克和卡托普利联合治疗。采用超声心动图检测治疗前后E峰、A锋、E/A、左房前后径。结果观察组治疗后E峰、A锋、E/A、左房前后径分别和对照组治疗后E峰、A锋、E/A、左房前后径比较,差异有统计学意义(P<0.05)。观察组总有效率高于对照组,差异有统计学意义(P<0.05)。结论倍他乐克联合卡托普利治疗能够显著改善舒张性心力衰竭患者的左心室舒张功能,效果显著。

Objective To explore the clinical efficacy of Betaloc combined with captopril in the treatment of diastolic heart failure. Methods In our hospital, 150 patients with diastolic heart failure were randomly divided into observation group and control group, the control group was accepted conventional heart failure treatment, the observation group was given to Betaloc combined with captopril on the basis of he conventional treatment. Echocardiography was used to detect E peak, A front, E/A, left atrial anterior posterior diameter. Results After treatment, the E peak, A front, E/A, left atrial anterior and posterior diameter in the observation group were compared with those in the control group after treatment, the difference was statistically significant（P〈0.05）. The total effective rate of the observation group was higher than that of the control group, the difference was statistically significant（P〈0.05）. Conclusion Betaloc combined with captopril can significantly improve left ventricular diastolic function in patients with diastolic heart failure,the clinical effect is significant.